Many areas of research and medicine rely critically upon knowing a person’s individual immune system proteins, as they determine an individual’s ability to fight disease or mistakenly attack their own tissues. However, obtaining this information is costly and difficult.
A new study, published February 29 in the open-access journal
PLoS Computational Biology, Listgarten et al demonstrate how statistical modeling can help researchers obtain this information more easily and cost effectively.
At the core of the human immune response is the train-to-kill mechanism in which specialized immune cells are sensitized to recognize small pieces of foreign pathogens (e.g., HIV). Following this sensitization, these cells are then activated to kill cells that display this same piece of pathogen. However, for sensitization and killing to occur, the pathogen must be “paired up” with one of the infected person’s specialized immune proteins—an HLA (human leukocyte antigen).
The way in which pathogen peptides interact with these HLA proteins defines if and how an immune response will be generated. Therefore, knowing which HLA proteins a person has is vital in transplant medicine, finding immunogenetic risk factors for disease, and understanding the way viruses like HIV mutate inside their host and evade the immune system.
The model uses a large set of previously measured, high-quality HLA data to find statistical patterns in this type of data. Using these patterns, the team from Microsoft Research, the National Cancer Institute, Massachusetts General, and the University of Oxford is able to take low-quality HLA data and clean it up so that it is of higher quality than that originally measured in the laboratory. With this publication, Listgarten and co-authors have made a public tool available to the research community so that others can improve the quality of their HLA data and thus study individual immune systems more effectively.
Citation: Listgarten J, Brumme Z, Kadie C, Xiaojiang G, Walker B, et al. (2008) Statistical Resolution of Ambiguous HLA Typing Data. PLoS Comput Biol 4(2): e1000016. doi:10.1371/journal.pcbi.1000016 (
http://www.ploscompbiol.org/doi/pcbi.1000016)
Source: Public Library of Science
Related stories:
New protocol streamlines therapy that makes more kidney transplants possible
A new therapy developed at Cedars-Sinai Medical Center improves transplant rates and outcomes for patients awaiting living- and deceased-donor kidney transplantation, according to a study published in the July 17 issue of the
New England Journal of Medicine.
Study points to 1 cause of higher rates of transplanted kidney rejection in blacks
A Johns Hopkins research team reports it may have an explanation for at least some of the higher organ rejection rates seen among black - as compared to white - kidney transplant recipients. In a study of 50 healthy adult men, 25 black and 25 white, significantly different amounts of certain immune system cells were found between the races.
Drug/radiation combo may help shrink established tumors
Researchers may be closer to understanding why anti-cancer drugs such as Ipilimumab, which boost the tumor-killing power of immune cells, haven't fared well in clinical trials. The new study, which describes a way to enhance the ability of these drugs to shrink well-established tumors, will be published online on August 25th in the
Journal of Experimental Medicine.
'Don't Worry Be Happy': happiness is key to longer life
Keep humming "Don't Worry Be Happy". The 1980s New Age-inspired hit got it right. New research shows being happy can add several years to life.
Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs
AIDS experts at Johns Hopkins say they have compelling evidence that some people with HIV who for years and even decades show extremely low levels of the virus in their blood never progress to full-blown AIDS and remain symptom free even without treatment, probably do so because of the strength of their immune systems, not any defects in the strain of HIV that infected them in the first place.
Novel method to create personalized immunotherapy treatments
Argos Therapeutics and Université de Montréal today announced the presentation of new information on Argos' process for developing dendritic cell-based immunotherapies for HIV. Results from the study demonstrate that loading monocyte-derived dendritic cells with combinations of HIV antigen RNA stimulates the expansion of HIV-specific T cells, which attack and kill HIV-infected cells.
Study: Spices may protect against consequences of high blood sugar
(PhysOrg.com) -- Herbs and spices are rich in antioxidants, and a new University of Georgia study suggests they are also potent inhibitors of tissue damage and inflammation caused by high levels of blood sugar.
Revolutionary technique could reduce lifelong drugs for transplant patients
Researchers have developed a ground-breaking procedure that could avoid the need for transplant patients to spend the rest of their lives taking a cocktail of drugs to stop their system from rejecting their new organ, according to a series of papers in the August issue of
Transplant International.